University of California, Santa Cruz, CA.
Igbinedion University, Okada, Nigeria.
Medicine (Baltimore). 2024 Jan 19;103(3):e36895. doi: 10.1097/MD.0000000000036895.
Heart failure (HF) poses a significant global health burden, necessitating a profound understanding of its multifaceted dimensions. This comprehensive review aims to unravel the etiology, decode pathophysiological mechanisms, navigate diagnostic modalities, explore pharmacological interventions, advocate lifestyle modifications, and chart the horizon of emerging therapies in the complex landscape of chronic cardiac dysfunction. The exploration of HF begins with an insightful journey into its diverse etiological factors, encompassing genetic predispositions, hypertension, and coronary artery disease. Delving into pathophysiological mechanisms, this review elucidates the intricate processes of cardiac remodeling, neurohormonal activation, and cellular dysfunction that underlie the progression of HF. Diagnostic modalities play a pivotal role in unraveling the mysteries of HF by examining advanced imaging techniques, biomarkers, and comprehensive clinical assessments. The pharmacological interventions section provides an in-depth analysis of traditional medications, such as diuretics and angiotensin-converting enzyme inhibitors, while highlighting the emergence of novel drug classes transforming HF management. Advocating lifestyle modifications emphasizes the crucial role of diet, exercise, smoking cessation, and alcohol moderation in enhancing patient outcomes. Lastly, the review delves into the promising horizon of emerging therapies, offering a glimpse into current research, innovative treatment approaches, and potential breakthroughs. As HF management faces challenges in patient compliance, healthcare access, and education, this comprehensive review aims to equip healthcare professionals and researchers with a holistic understanding of chronic cardiac dysfunction's intricacies. In conclusion, synthesizing key findings emphasizes the need for an integrated and multidimensional approach to effectively address the complex landscape of heart failure.
心力衰竭(HF)是一个重大的全球健康负担,需要深入了解其多方面的维度。本综述旨在阐明病因学,解码病理生理机制,探索诊断方法,研究药物干预措施,倡导生活方式的改变,并探讨慢性心功能障碍复杂领域中新兴治疗方法的前景。HF 的探索始于深入了解其多种病因,包括遗传易感性、高血压和冠状动脉疾病。本综述深入探讨病理生理机制,阐明了心力衰竭进展所涉及的心脏重构、神经激素激活和细胞功能障碍的复杂过程。诊断方法通过检查先进的成像技术、生物标志物和全面的临床评估,在揭示 HF 的奥秘方面发挥着关键作用。药物干预部分对传统药物(如利尿剂和血管紧张素转换酶抑制剂)进行了深入分析,同时强调了改变 HF 管理的新型药物类别的出现。倡导生活方式的改变强调了饮食、运动、戒烟和限制饮酒在改善患者预后方面的重要作用。最后,综述深入探讨了新兴治疗方法的广阔前景,展示了当前的研究、创新的治疗方法和潜在的突破。由于 HF 管理在患者依从性、医疗保健可及性和教育方面面临挑战,本综述旨在为医疗保健专业人员和研究人员提供对慢性心功能障碍复杂性的全面理解。总之,综合关键发现强调需要采取综合和多维的方法来有效应对心力衰竭的复杂局面。